EP4108233A1 — Oral solution comprising a cinacalcet salt
Assigned to Faran SA · Expires 2022-12-28 · 3y expired
What this patent protects
Oral pharmaceutical solution comprising a pharmaceutically acceptable cinacalcet salt and a pharmaceutically acceptable carrier comprising a mixture of propylene glycol and a polyethylene glycol, or a mixture of two polyethylene glycols, a polyol, a polymer selected from polyviny…
USPTO Abstract
Oral pharmaceutical solution comprising a pharmaceutically acceptable cinacalcet salt and a pharmaceutically acceptable carrier comprising a mixture of propylene glycol and a polyethylene glycol, or a mixture of two polyethylene glycols, a polyol, a polymer selected from polyvinylpyrrolidone and/or copovidone, water, and a buffer, wherein the pH of the solution is from 4.0 to 7.5.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.